— Your child’s backpack may be incredibly handy and reflect
Alnylam Completes Enrollment in ENVISION Phase 3 Study of Givosiran, an Investigational RNAi Therapeutic for the Treatment of Acute Hepatic Porphyrias (AHPs)
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aug. 21, 2018– Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY),
Researchers identify potential target for treating pain during surgery
A research team lead by faculty of the University of
STD Rates Rise for the 4th Consecutive Year
There are many types of sexually transmitted diseases.* In fact,
CDC approves nasal-spray vaccine for flu season
After advising the public to avoid the nasal-spray version of
John McCain no longer receiving treatment for terminal brain tumor
(HealthDay)—Senator John McCain’s long battle with brain cancer may be
Researchers test autobiographical memory for early Alzheimer’s detection
Testing how well people remember past events in their lives
First drug approved for rare eye disease
(HealthDay)—Oxervate (cenegermin) has been approved by the U.S. Food and
Researchers find potential new gene therapy for blinding disease
The last year has seen milestones in the gene therapy
Genetically modified mosquitoes may be best weapon for curbing disease transmission
Mosquitoes are some of the most deadly creatures on the